Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $21,344,960 | $20,118,560 | $18,781,200 | $16,745,460 |
| - Cash | $432,000 | $319,000 | $188,000 | $549,000 |
| + Debt | $6,382,000 | $6,384,000 | $6,570,000 | $6,925,000 |
| Enterprise Value | $27,294,960 | $26,183,560 | $25,163,200 | $23,121,460 |
| Revenue | $2,816,000 | $2,761,000 | $2,652,000 | $2,621,000 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Gross Profit | $949,000 | $943,000 | $863,000 | $858,000 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| EBITDA | $547,000 | $596,000 | $488,000 | $507,000 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |
| Net Income | $245,000 | $282,000 | $220,000 | $222,000 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| % Growth | -12.6% | 27.3% | -0.5% | – |
| Operating Cash Flow | $563,000 | $544,000 | $314,000 | $464,000 |
| Capital Expenditures | -$144,000 | -$108,000 | -$117,000 | -$123,000 |
| Free Cash Flow | $419,000 | $436,000 | $197,000 | $341,000 |